Barrera SL and Barrera DL are dehydrated amniotic membrane allograft.
INTENDED USES: Barrera SL and Barrera DL are intended to serve as a protective wound cover or barrier to offer protection from the surrounding environment in wounds, including surgically created wounds.
CLAIMED BENEFITS: Barrera SL and Barrera DL are supplied in a single layer form or dual layer form. Barrera SL and Barrera DL are for topical application in one patient on a single occasion. The dosage for Barrera SL and Barrera DL amniotic membrane allograft is per square centimeter. Barrera is available in various sizes.
OPTIONS: Per Square Centimeter
The addition of Skin Substitutes or Cellular or Tissue Based Products (CTPs) to certain wounds may afford a healing advantage over dressings and conservative treatments when these options appear insufficient to affect complete healing, after at least a 30 day period of comprehensive conservative therapy. There are currently a wide variety of bioengineered products available for soft tissue coverage to affect closure. • Human skin allografts are derived from donated human skin (cadavers) • Allogeneic matrices are derived from human tissue (fibroblasts or membrane) • Composite matrices are derived from human keratinocytes, fibroblasts and xenogeneic collagen • Acellular matrices are derived from xenogeneic collagen or tissue
For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care